Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

March 2017 | 115 pages | ID: G7D352BC4D3EN
S&P Consulting

Abstracts

The Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-alcoholic Fatty Liver Disease (NAFLD) Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Regional Segment Analysis

Global
China

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Product Segment Analysis

Type I
Type II
Type III

Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Application Segment Analysis

Application I
Application II
Application III

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global and China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021
c 1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
1.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Definition
1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Classification and Application
1.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Chain
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Overview

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
  3.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)
3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Revenue by Type
  3.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type (2012-2017)
  3.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
3.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Revenue by Application

CHAPTER 4 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET ANALYSIS

4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Revenue (2012-2014)
  4.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Growth Rate (2012-2014)
  4.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2014)
  4.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2014)
4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Manufacturers
4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type
4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Application

CHAPTER 5 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURERS ANALYSIS

5.1 Conatus Pharmaceuticals
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Product Type, Application and Specification
  5.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 Daewoong Pharmaceutical
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Product Type, Application and Specification
  5.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Galmed International
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Product Type, Application and Specification
  5.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 Kyorin Pharmaceutical
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Product Type, Application and Specification
  5.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 Metabolic Solutions Development
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Product Type, Application and Specification
  5.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 Novartis AG
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Product Type, Application and Specification
  5.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Phenex Pharmaceuticals
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Product Type, Application and Specification
  5.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Raptor Pharmaceuticals
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Product Type, Application and Specification
  5.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 TCM Biotech International
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Product Type, Application and Specification
  5.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURING COST ANALYSIS

6.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET FORECAST (2017-2021)

8.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue Forecast (2017-2021)
8.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
8.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)
8.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption Forecast by Regions (2017-2021)
8.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Forecast (2017-2021)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2015
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2016
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production of Key Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 Manufacturers
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 5 Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Type (2012-2017)
Figure Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure 2015 Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Price Trend (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Application (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Galmed International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table TCM Biotech International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Growth Rate Forecast (2017-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Consumption Forecast by Regions (2017-2021)

COMPANIES MENTIONED

Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen